The University of Melbourne has entered into a drug development deal with Procypra Therapeutics, a US start-up company established by Collaborative Medicinal Development under the umbrella of venture capital firm Cthulhu Ventures. [ + ]

Health researchers at the University of Florida have found a quick and cheap way to test for early-stage Alzheimer's disease. The only equipment necessary is a container of peanut butter and a ruler. [ + ]

Novogen (ASX:NRT) has licensed Australian-developed drug technology with the potential to replace the popular class of chemotherapeutics that target the cytoskeleton of cancer cells. [ + ]

Professor Alan Cowman from the Walter and Eliza Hall Institute has been awarded the 2013 Victoria Prize for Science and Innovation in recognition of his outstanding contributions in the quest to eradicate malaria. [ + ]

CSL (ASX:CSL) has negotiated a proposed settlement to a US class action antitrust lawsuit centred around the company's control of supply of plasma-derived protein therapeutics. [ + ]

Modifying baker's yeast to produce a synthetic form of the natural chemical limonene may provide a much-needed future alternative to fossil fuels. [ + ]

The University of Queensland (UQ) has entered a three-year collaboration with Denmark-based pharmaceutical company LEO Pharma with the aim of delivering new treatment options to patients suffering from skin cancer. [ + ]

Clinical Genomics - the developer of a blood-based biomarker test in collaboration with CSIRO Preventative Health Flagship and the Flinders Centre for Innovation in Cancer - has acquired US-based screening company Enterix from Quest Diagnostics, as well as its Sydney-based subsidiary. [ + ]

After a positive meeting with the US FDA, QRxPharma (ASX:QRX) aims to resubmit its application for approval of pain drug MoxDuo in mid-November. [ + ]

Orthocell's results from a clinical study of its Ortho-ATI technology for regenerating damaged tendons have been published in The American Journal of Sports Medicine. [ + ]

Eight surgeons, based at The Prince Charles Hospital in Brisbane, were today approved to use Allied Healthcare's (ASX: AHZ) CardioCel to repair and treat heart defects in adult patients under the Authorised Prescriber Scheme (APS). [ + ]

Bionomics (ASX:BNO) has received additional decisions from Innovation Australia in relation to the company's applications for an advance finding under the R&D Tax Incentive. [ + ]

Laboratory and pharmaceutical equipment provider Sartorius Stedim Biotech has made a cash offer to acquire UK company TAP Biosystems through its wholly owned subsidiary, Sartorius Stedim Biotech GmbH. [ + ]

UK-headquartered contract organisation TranScrip Partners has opened a new office in Hong Kong. This follows recent openings in Australia and the US and is underpinned by the continuing increase of contracts in the Asia-Pacific region. [ + ]

Three scientists' work on a major transport system in cells has won them the 2013 Nobel Prize in Physiology or Medicine. [ + ]